ATA290380A - Verfahren zur herstellung eines geformten und komprimierten therapeutischen praeparates mit verzoegerter wirstoffabgabe - Google Patents

Verfahren zur herstellung eines geformten und komprimierten therapeutischen praeparates mit verzoegerter wirstoffabgabe

Info

Publication number
ATA290380A
ATA290380A AT802903A AT290380A ATA290380A AT A290380 A ATA290380 A AT A290380A AT 802903 A AT802903 A AT 802903A AT 290380 A AT290380 A AT 290380A AT A290380 A ATA290380 A AT A290380A
Authority
AT
Austria
Prior art keywords
oxygen
producing
shaped
therapeutic preparation
delayed delivery
Prior art date
Application number
AT802903A
Other languages
English (en)
Other versions
AT373147B (de
Inventor
Joseph M Schor
Original Assignee
Forest Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories filed Critical Forest Laboratories
Priority to AT461282A priority Critical patent/AT373778B/de
Publication of ATA290380A publication Critical patent/ATA290380A/de
Application granted granted Critical
Publication of AT373147B publication Critical patent/AT373147B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0290380A 1979-06-14 1980-06-02 Verfahren zur herstellung eines geformten und komprimierten therapeutischen praeparates mit verzoegerter wirkstoffabgabe AT373147B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT461282A AT373778B (de) 1979-06-14 1982-12-20 Traegermaterial fuer medikamente und verfahren zu seiner herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/048,344 US4226849A (en) 1979-06-14 1979-06-14 Sustained release therapeutic compositions

Publications (2)

Publication Number Publication Date
ATA290380A true ATA290380A (de) 1983-05-15
AT373147B AT373147B (de) 1983-12-27

Family

ID=21954071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0290380A AT373147B (de) 1979-06-14 1980-06-02 Verfahren zur herstellung eines geformten und komprimierten therapeutischen praeparates mit verzoegerter wirkstoffabgabe

Country Status (17)

Country Link
US (1) US4226849A (de)
JP (1) JPS565413A (de)
AT (1) AT373147B (de)
BE (1) BE883779A (de)
CA (1) CA1141295A (de)
CH (1) CH650685A5 (de)
DE (2) DE3050558C2 (de)
ES (1) ES492205A0 (de)
FR (1) FR2459049A1 (de)
GB (1) GB2061950B (de)
IL (1) IL58279A (de)
IT (1) IT1136186B (de)
NL (1) NL192324C (de)
PL (1) PL134410B1 (de)
SE (1) SE449179B (de)
YU (1) YU41736B (de)
ZA (1) ZA796086B (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4842854A (en) * 1979-05-29 1989-06-27 Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskiki Nauk Ssr Antianginal plate for treating ischemic heart disease
US4357469A (en) * 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
IE49324B1 (en) * 1979-12-19 1985-09-18 Euro Celtique Sa Controlled release compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
DE3125178A1 (de) * 1981-06-26 1983-01-13 Gödecke AG, 1000 Berlin Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
DE3479122D1 (en) * 1983-10-14 1989-08-31 Eastman Kodak Co Carboxylated cellulose ester
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61218516A (ja) * 1985-03-25 1986-09-29 Ichimaru Fuarukosu Kk 徐放性マイクロカプセルの製造法
US4657757A (en) * 1985-03-29 1987-04-14 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
US4601894A (en) * 1985-03-29 1986-07-22 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US4738851A (en) * 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
US4859467A (en) * 1986-09-25 1989-08-22 Colgate-Palmotive Company Sustained release fluoride composition
US4861590A (en) * 1986-09-25 1989-08-29 Colgate-Palmolive Company Sustained release fluoride and calcium composition
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
GB8802391D0 (en) * 1988-02-03 1988-03-02 Ddsa Pharmaceuticals Ltd Medicinal formulations
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
DE3834794A1 (de) * 1988-10-12 1990-04-19 F Schielein Oral zu verabreichendes mittel zur behandlung von psoriasis
ES2079485T3 (es) * 1989-08-25 1996-01-16 Bioglan Ireland R & D Ltd Composiciones farmaceuticas y un dispositivo para administrar las mismas.
JP2845342B2 (ja) * 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
EP0465992B1 (de) * 1990-07-02 1998-06-17 Aqualon Company Niedrigviskose-Polysaccharidzusammensetzung mit hohem Festkörpergehalt
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
ATE374607T1 (de) * 1994-05-27 2007-10-15 Strakan Int Ltd Zusammensetzung enthaltend stickstoffoxid- donatoren und methode zur behandlung analer krankheiten
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
US20050064033A1 (en) * 1997-04-11 2005-03-24 Notario Gerard F. Extended release formulations of erythromycin derivatives
US6551616B1 (en) * 1997-04-11 2003-04-22 Abbott Laboratories Extended release formulations of erythromycin derivatives
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
DE19842753A1 (de) * 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US20020169145A1 (en) * 1998-10-14 2002-11-14 Rajen Shah Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20060127474A1 (en) * 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
US20040247746A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Delivery units of thick orally soluble polymer
US20050003048A1 (en) * 2002-02-11 2005-01-06 Edizone, Lc Electrolyte-containing orally soluble films
WO2003105810A1 (en) * 2002-06-14 2003-12-24 Andrx Corporation Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2004249211A1 (en) * 2003-06-16 2004-12-29 Andrx Pharmaceuticals, Llc Oral extended-release composition
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1653925A1 (de) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robustes pellet
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005023184A2 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
AU2008261957A1 (en) * 2007-06-08 2008-12-18 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
WO2009005923A1 (en) * 2007-07-05 2009-01-08 Dow Global Technologies Inc. In situ, liquid-activated film coated tablets and a process for making the same
RU2013135224A (ru) 2011-01-20 2015-03-10 Бионевиа Фармасьютикалс Инк. Композиции с модифицированным высвобождением эпалрестата или его производных и способы их использования
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN112704668B (zh) * 2021-01-12 2022-09-30 石药集团中奇制药技术（石家庄）有限公司 一种盐酸普拉克索缓释组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2726982A (en) * 1950-05-24 1955-12-13 Irving L Ochs Hydrous gels
US3034964A (en) * 1954-03-29 1962-05-15 Vitamix Pharmaceuticals Inc Sustained action tablet containing oxytetracycline
US2949401A (en) * 1958-07-28 1960-08-16 Dome Chemicals Inc Buccal tablet containing vitamin a
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3251824A (en) * 1961-08-22 1966-05-17 Fmc Corp Method of preparing stable aqueous dispersion-forming cellulosic aggregates
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
GB1171691A (en) 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
GB1279214A (en) * 1970-01-22 1972-06-28 Forest Laboratories Long-acting oral carrier
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US3852421A (en) * 1970-03-23 1974-12-03 Shinetsu Chemical Co Excipient and shaped medicaments prepared therewith
FR2183546B1 (de) * 1972-05-10 1975-06-20 Servier Lab
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
US3896108A (en) * 1974-05-10 1975-07-22 Hercules Inc Carboxyalkyl modified ethyl cellulose
US4136145A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein

Also Published As

Publication number Publication date
IT1136186B (it) 1986-08-27
SE8004284L (sv) 1980-12-15
NL192324B (nl) 1997-02-03
NL8003214A (nl) 1980-12-16
YU146980A (en) 1983-04-30
PL224943A1 (de) 1981-03-13
AT373147B (de) 1983-12-27
NL192324C (nl) 1997-06-04
DE3050558C2 (de) 1985-04-18
DE3020724C2 (de) 1985-02-21
IT8012572A0 (it) 1980-06-13
FR2459049A1 (fr) 1981-01-09
GB2061950B (en) 1983-03-30
CH650685A5 (it) 1985-08-15
PL134410B1 (en) 1985-08-31
CA1141295A (en) 1983-02-15
YU41736B (en) 1987-12-31
ZA796086B (en) 1980-11-26
ES8104911A1 (es) 1981-05-16
US4226849A (en) 1980-10-07
DE3020724A1 (de) 1981-01-29
FR2459049B1 (de) 1984-03-16
IL58279A0 (en) 1979-12-30
IL58279A (en) 1982-11-30
GB2061950A (en) 1981-05-20
BE883779A (fr) 1980-10-01
SE449179B (sv) 1987-04-13
JPS565413A (en) 1981-01-20
ES492205A0 (es) 1981-05-16
DE3050558A1 (de) 1982-07-22

Similar Documents

Publication Publication Date Title
ATA290380A (de) Verfahren zur herstellung eines geformten und komprimierten therapeutischen praeparates mit verzoegerter wirstoffabgabe
ATA290884A (de) Verfahren zur herstellung eines arzneimittelpraeparates mit kontrollierter und gleichmaessiger freigabe des arzneimittelwirkstoffes
ATA177587A (de) Verfahren zur herstellung eines stabilen pharmazeutischen präparats mit einem gehalt an granulozytkolonie stimulierendem faktor
AT354636B (de) Verfahren zur herstellung eines praeparates mit gesteuerter abgabe einer aktiven komponente
PT71490A (de) Verfahren zur herstellung neuer cyclopeptide und pharmazeutische praparate davon
ATA115186A (de) Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung
AT386744B (de) Verfahren zur herstellung eines wundheilmittels
DE3862554D1 (de) Aufbau eines schleifenbandes und verfahren zur herstellung desselben.
ATA903983A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
AT361280B (de) Verfahren zur herstellung eines stabilen nahrungs- und futtermittels
AT351159B (de) Verfahren zur herstellung eines cephalexin- praeparates mit teilweise verzoegerter wirkstoff- abgabe zur oralen verabreichung beim menschen
DE2920890A1 (de) Neue physiologisch aktive derivate des esterastins sowie verfahren zur herstellung derselben
AT388670B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung mit einem gehalt an calciumantagonisten
AT364173B (de) Verfahren zur herstellung eines hartstoffes und verwendung des hergestellten hartstoffes
AT382236B (de) Verfahren zur herstellung eines splitterkoerpers und danach hergestellter splitterkoerper
ATA133784A (de) Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten
ATA323275A (de) Verfahren zur herstellung eines verbundkorpers und danach hergestellter verbundkorper
ATA327685A (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
AT360644B (de) Verfahren zur herstellung eines mittels zur prophylaxe und therapie der gastroenteritis von primaten
AT374365B (de) Verfahren zur herstellung eines pharmazeutischen praeparates
JPS5644456A (en) Needle valve and method of producing thereof
AT347921B (de) Verfahren zur herstellung von neuen 3- (4'-p- halogenphenoxyphenyl)-2-buten-1-olen und -butan-1-olen sowie deren alkansaeureestern
ATA919076A (de) Verfahren zur herstellung von neuen hydroxy- aethyliden-cyanessigsaeure-aniliden sowie von deren physiologisch vertraeglichen salzen
AT346479B (de) Verfahren zur herstellung eines neuen antibioticum-gemisches und seiner komponenten
AT374366B (de) Verfahren zur herstellung einer teilbaren tablette mit kontrollierter und verzoegerter wirkstoffabgabe

Legal Events

Date Code Title Description
ELA Expired due to lapse of time